Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gretta Blatner"'
Autor:
Dhanasekaran Sivakumaran, Gretta Blatner, Rasmus Bakken, David Hokey, Christian Ritz, Synne Jenum, Harleen M. S. Grewal
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Despite the widespread use of BCG, tuberculosis (TB) remains a global threat. Existing vaccine candidates in clinical trials are designed to replace or boost BCG which does not provide satisfying long-term protection. AERAS-402 is a replication-defic
Externí odkaz:
https://doaj.org/article/e3879b7a5ea64e3594a377e97420e50c
Autor:
Kathryn Amass, Xiaomi M. Tong, Eric M. Espeland, James C. King Jr., Robert J. Hopkins, Gloria David, Gretta Blatner, Gary Horwith, Daniel N. Wolfe, Yonghong Gao, Di Lu, Brett Jepson
Publikováno v:
Vaccine. 38:7970-7976
Background Multiple Anthrax vaccines are licensed or in development for post-exposure prophylaxis in individuals 18 to 65 years of age. No information exists on anthrax vaccines in populations over the age of 65. It is critical that we assess the cap
Autor:
Simon Mallal, Richard Copin, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Elizabeth J. Phillips, Joel D. Ernst, Steven J. Mack, Shay Leary, Gretta Blatner, Heather Siefers
Publikováno v:
Human immunology. 78(4)
One hundred healthy infants enrolled as controls in a tuberculosis vaccine study in Nyanza Province, Kenya provided anonymized samples for DNA sequence-based typing at the HLA-A, -B, -C, -DPB1, -DQA1, -DQB1, -DRB1, and -DRB3/4/5 loci. The purpose of
Autor:
David Hokey, Michele Tameris, Dawn Henson, Veerabadran Dheenadhayalan, Gretta Blatner, Bruce McClain, Robert Walker, Mark Hatherill, Videlis Nduba, Jahit Sacarlal, Glenda Gray, Jenny Hendriks, Maria Pau, Macaya Douoguih, Jerald Sadoff, Lewellys Barker
Publikováno v:
The Journal of Immunology. 194:73.4-73.4
Despite widespread use of BCG, tuberculosis (TB) remains a global threat, with 9 million new cases and 1.5 million deaths reported in 2013. Current vaccine candidates in clinical trials are designed to replace BCG or boost the variable efficacy obser
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14:A29